All In Biotech

Drug Trial Radar · NCT04138836

Assess the Drug Interactions of BBT-877 and Midazolam, Itraconazole, and Esomeprazole in Healthy Adult Subjects

A 3-Part, Phase 1 Study to Assess the Drug Interactions of BBT-877 and Midazolam, Itraconazole, and Esomeprazole in Healthy Adult Subjects

Last checked: Nov 19, 2026Latest source record: Jan 18, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

48

Actual

Start

Sep 17, 2019

Primary completion

Nov 4, 2019

Study completion Nov 4, 2019

Sponsor

Lead sponsor
Bridge Biotherapeutics, Inc.Industry
Sponsor type
Industry
Collaborators
KCRN Research, LLC
First posted
Oct 25, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 19 years, up to 55 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Study to determine the effect of multiple-dose BBT-877 on the single-dose pharmacokinetics of midazolam, the safety and tolerability of a single dose of BBT-877 administered alone and with multiple doses of itraconazole, and the effect of multiple-dose esomeprazole on the single-dose pharmacokinetics of BBT-877, in healthy adult subjects.

Conditions

  • Healthy Participants

Interventions

  • BBT-877Drug

    BBT-877 oral capsule.

  • MidazolamDrug

    Midazolam oral syrup.

  • ItraconazoleDrug

    Itraconazole oral capsule.

  • EsomeprazoleDrug

    Esomeprazole oral capsule.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. AUC (the area under the curve) [Pharmacokinetics]Time frame: Day 1 of period 1 and Day 10 (Arm 1), 5 (Arm 2), or 5 (Arm 3) of period 2
  2. Cmax (peak concentration) [Pharmacokinetics]Time frame: Day 1 of period 1 and Day 10 (Arm 1), 5 (Arm 2), or 5 (Arm 3) of period 2

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Celerion

    Lincoln, Nebraska

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.